Skip to main content

CL9 4.5 mg (Rivastigmine Tartrate 4.5 mg)

Pill with imprint CL9 4.5 mg is Red, Capsule-shape and has been identified as Rivastigmine Tartrate 4.5 mg. It is supplied by Macleods Pharmaceuticals Limited.

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 4.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL9 4.5 mg

Rivastigmine Tartrate

Imprint
CL9 4.5 mg
Strength
4.5 mg
Color
Red
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Macleods Pharmaceuticals Limited
National Drug Code (NDC)
33342-0091
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, silicon dioxide, gelatin, titanium dioxide, sodium lauryl sulfate, ferric oxide red, ferric oxide yellow, hypromelloses

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.